Article info
Clinical science
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
- Correspondence to Professor Justine R Smith, Flinders University School of Medicine, Flinders Medical Centre Room 4E-431, Flinders Drive, Bedford Park, SA 5042, Australia; justine.smith{at}flinders.edu.au
Citation
Use of intravitreal rituximab for treatment of vitreoretinal lymphoma
Publication history
- Received July 19, 2013
- Revised September 20, 2013
- Accepted September 23, 2013
- First published October 24, 2013.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions